New clinical study links Euromed’s Pomanox® to improved key biomarker of ageing Mollet del Vallès (Spain), October 2025 – A double-blind, randomised, placebo-controlled clinical trial published in Nutrients reveals that daily supplementation with Pomanox® leads to a statistically significant increase in insulin-like growth factor-1 (IGF-1) in older adults.[1] IGF-1 supports normal cell growth and repair, and typically declines with age. Pomanox® is a patented, high-polyphenol pomegranate … [Read more...] about Pomegranate polyphenols may support longevity
Pomegranate
Research links pomegranate extract with improved liver health
Pre-clinical study with Pomanox® shows beneficial effects on metabolism after fructose consumption and reduced risk of obesity-related harm Mollet del Vallès (Spain), June 2024: A recently published pre-clinical study reveals the potential effects of pomegranate extract supplementation on the health issues associated with high fructose consumption. In an animal model, Pomanox® from botanical ingredients producer Euromed was able to counteract lipid deposition, dyslipidemia, and fatty … [Read more...] about Research links pomegranate extract with improved liver health
Pomegranate extract linked to eye health benefits
In-vitro study explores the potential of Pomanox® as an ocular anti-inflammatory agent Mollet del Vallès (Spain), May 2023: A recently published study in the Journal of Clinical and Translational Ophthalmology shows the anti-inflammatory effect of Euromed’s Pomanox® in a common cell model for testing eye damage and irritation.[1] This trial suggests for the first time that the pomegranate extract may have potential as an ocular anti-inflammatory agent, which could be promising for the growing … [Read more...] about Pomegranate extract linked to eye health benefits
